The Medical Research Council (MRC) has launched a new £5m call for capital investment to support between two and five human tissue banks with linked data resources. Awards will be made to teams of academics working in close partnership with medical research charities.
In stroke survivors, does the clinical effectiveness of 6 months treatment with fluoxetine depend upon its effects on synaptic plasticity in the brain? Can a drug used for depression help stroke recovery by changing connections between brain cells?
These summaries of our completed research projects highlight what work was undertaken, which aims were achieved and where the research is going next.
It's estimated that about half of people admitted to hospital with a stroke will have lost control of their bladder, and a third will experience loss of bowel control. Last week, a research incontinence workshop was held at Guy's Hospital London, with the aim of stimulating research into incontinence.
CADASIL is one of the most common genetic causes of stroke and dementia. Currently there is no treatment for CADASIL. In this study, human stem cells will be generated from a piece of skin donated by patients with CADASIL. From these stem cells, smooth muscle cells (SMCs) will be generated in a tissue culture dish in the lab.
The National Institute of Clinical Excellence (NICE) are currently welcoming applications from people who would like to join the groups that develop Quality Standards.
A panel of independent experts has decided that alteplase, a clot-busting drug often used to treat strokes is safe and effective under current guidelines.
Published in the journal Age and Ageing, a new systematic review of the current research suggests that anticoagulant drugs may have cognitive benefit for those with AF (atrial fibrillation).
What maintains stroke survivors’ continued use of self-managed computer therapy for aphasia?